Stay updated with breaking news from Device Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LDGraft is a next-generation bone graft substitute for spinal fusion, with uniquely encapsulated rhBMP-2 for controlled and extended-release Seeking to target significant and growing chronic low
Conference call to discuss financial and operational results scheduled for Thursday, March 16, at 8:30 a.m. U.S. Eastern Time Executed global licensing and...
Dr. Valluvan Jeevanandam and Dr. Christopher Salerno spoke to The Maroon about UChicago Medicine’s record-setting numbers.
UChicago Medicine, which is pushing further into the Northwest Indiana market with a micro-hospital in Crown Point, did 66 heart transplants last year.
GOTHENBURG, SE / ACCESSWIRE / September 20, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)